<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    AcelRx Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About AcelRx Pharmaceuticals, Inc.

    AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $95,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Vincent J. Angotti
    • FOUNDED
      2005
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Paratek Pharmaceuticals, Inc.

    Paratek Pharmaceuticals, Inc.

    Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focu...

    Paratek Pharmaceuticals, Inc. is a commercial-s...

    Filing Type:    PU
    AxoGen, Inc.

    AxoGen, Inc.

    Axogen (AXGN) is a global leader in innovative surgical solutions for peripheral n...

    Axogen (AXGN) is a global leader in innovative ...

    Filing Type:    PU
    DURECT Corporation

    DURECT Corporation

    DURECT is a biopharmaceutical company actively developing therapeutics based on it...

    DURECT is a biopharmaceutical company actively ...

    Filing Type:    PU
    Aimmune Therapeutics, Inc.

    Aimmune Therapeutics, Inc.

    Aimmune Therapeutics, Inc. (Nasdaq: AIMT), is a clinical-stage biopharmaceutical c...

    Aimmune Therapeutics, Inc. (Nasdaq: AIMT), is a...

    Filing Type:    PU
    Trevi Therapeutics, Inc.

    Trevi Therapeutics, Inc.

    We are developing nalbuphine ER to treat serious neurologically mediated condition...

    We are developing nalbuphine ER to treat seriou...

    Filing Type:    PU
    Viking Therapeutics, Inc.

    Viking Therapeutics, Inc.

    Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the d...

    Viking Therapeutics is a clinical-stage biophar...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.